AstraZeneca said its COVID-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April.
AstraZeneca reports $275M in sales from vaccine during 1st quarter
© The Crystal Eyes
AstraZeneca said its COVID-19 vaccine sales were $275 million in the first-quarter and it is on track to deliver 200 million doses a month from April.
© The Crystal Eyes